ProCE Banner Events

A New Perioperative Treatment Option for Patients with Resectable Non-Small Cell Lung Cancer

Learn about an exciting new indication for a perioperative treatment option for certain resectable NSCLC patients.

Key Takeaways:

  • Provide a deep-dive of key efficacy and safety outcomes from the clinical trial
  • Understand other clinical parameters, such as dosing and select subgroup data
  • Discuss how the data from this trial can help inform treatment decisions
  • Open Q&A time to ask a peer about their perspectives
Time and location

Wednesday, November 13, 2024

12:15 PM - 1:00 PM Eastern Time (ET)

Virtual

Faculty
Jason Porter, MD

Thoracic Oncologist, West Cancer Center & Research Institute
Memphis, Tennessee

Sponsored By

Bristol Myers Squibb

ProCE Banner

ONC-US-2400611